Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
WA
WallStreetWontons
Community Contributor
Hims & Hers are taking grip on Telemedicine
Catalysts Financial Performance : In 2023 , Hims & Hers reported impressive financial results: Revenue : Reached $872.0 million , reflecting a 65% year-over-year increase. Net Income : Achieved $1.2 million in Q4 2023.
View narrativeUS$17.15
FV
52.8% overvalued intrinsic discount100.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
5 months ago author updated this narrative
WA
Consensus Narrative from 13 Analysts
Expansion Into New Specialties May Attract Consumers, But Marketing Costs And Regulatory Risks Could Strain Margins
Key Takeaways Expansion into new medical specialties and personalized solutions are expected to drive broad consumer attraction and future revenue growth. Technological advancements and operational efficiency improvements aim to enhance margins and optimize resource allocation.
View narrativeUS$24.90
FV
5.2% overvalued intrinsic discount30.97%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
10 days ago author updated this narrative